Tyrosine kinases

Tyrosine kinases
ajc3527 · CC BY-SA 4.0 · source
Name	Tyrosine kinases
Classification	Enzyme
Function	Protein phosphorylation
Pathway	Signal transduction

Tyrosine kinases are a class of enzymes that catalyze transfer of a phosphate group to tyrosine residues on substrate proteins, playing central roles in cell communication and physiology. Discovered through studies involving oncogenes and viral agents such as Rous sarcoma virus and researchers like Peter Nowell and Harold Varmus, they link extracellular cues to intracellular responses in processes ranging from Embryogenesis to Hemostasis. Dysregulation of these enzymes underpins many disorders studied at institutions like the National Institutes of Health and treated in settings including the Mayo Clinic and Memorial Sloan Kettering Cancer Center.

Introduction

Tyrosine kinases arose in the literature through landmark work by teams including J. Michael Bishop and Harold E. Varmus at the University of California, San Francisco, and later structural and biochemical elucidation by groups at the Max Planck Society and Cold Spring Harbor Laboratory. Their importance became evident in oncology contexts involving cases studied at Dana-Farber Cancer Institute and through drug development programs at pharmaceutical firms such as Pfizer, Novartis and GlaxoSmithKline. Foundational reviews appeared in journals associated with organizations like the American Association for Cancer Research and the European Molecular Biology Organization.

Classification and Structure

Tyrosine kinases divide into receptor tyrosine kinases and non-receptor (cytoplasmic) tyrosine kinases, classifications refined by consortia including the Human Genome Organisation and researchers at Wellcome Trust Sanger Institute. Receptor families include members related to Epidermal growth factor receptor and Platelet-derived growth factor receptor, while non-receptor families align with proto-oncogenes such as SRC, ABL1, JAK2 and SYK. Structural determination by groups at European Molecular Biology Laboratory and Ruth Nussenzweig-associated labs revealed conserved kinase domains with N-lobe and C-lobe architecture, activation loops, and regulatory motifs analogous to domains found in proteins studied at Harvard Medical School and Stanford University School of Medicine.

Biological Functions and Signaling Pathways

Tyrosine kinases orchestrate signaling cascades implicated in processes investigated at the Salk Institute and Johns Hopkins University, including cell proliferation, migration, differentiation and immune responses characterized in studies from the Pasteur Institute. They participate in canonical pathways such as those involving MAPK and PI3K axes, intersecting with adaptor proteins characterized in labs at Massachusetts Institute of Technology and with receptors studied at UCSF Medical Center. In hematopoiesis, kinases like JAK2 interact with cytokine receptors described in clinical reports from Cleveland Clinic and trials conducted through European Organisation for Research and Treatment of Cancer.

Regulation and Mechanisms of Activation

Activation mechanisms include ligand-induced dimerization exemplified by Epidermal growth factor, trans-autophosphorylation events analyzed in structural studies at the Max Planck Institute, and relief of autoinhibitory interactions elucidated by teams at Cold Spring Harbor Laboratory. Post-translational regulation involves ubiquitination pathways studied at Ludwig Institute for Cancer Research and phosphatases such as PTP1B examined by researchers at University of Cambridge. Allosteric modulation and ATP-competitive inhibition informed drug design efforts at AstraZeneca and Bristol-Myers Squibb.

Role in Disease and Therapeutic Targeting

Oncogenic mutations in kinases such as BCR-ABL1 and amplification of receptors like HER2 were pivotal in cancer medicine advances at Memorial Sloan Kettering Cancer Center and led to targeted therapies exemplified by Imatinib and Trastuzumab developed by Novartis and Genentech respectively. Aberrant kinase signaling contributes to disorders reported in cohorts from Mayo Clinic and Johns Hopkins Hospital, including myeloproliferative neoplasms with JAK2 V617F mutations and autoimmune conditions investigated in studies at Karolinska Institutet. Resistance mechanisms mediated by secondary mutations or bypass signaling are subjects of trials registered by Food and Drug Administration and managed in networks like National Cancer Institute clinical cooperative groups.

Experimental Methods and Detection

Detection and quantification techniques include immunoblotting with phospho-tyrosine antibodies standardized in protocols at Cold Spring Harbor Protocols and mass spectrometry workflows pioneered at European Molecular Biology Laboratory and Broad Institute. Structural studies employ X-ray crystallography and cryo-electron microscopy conducted at facilities such as Diamond Light Source and Cryo-EM Facility, University of California. Functional screens utilize CRISPR tools developed at Broad Institute and small-molecule libraries curated by organizations like the Structural Genomics Consortium.

Evolution and Comparative Genomics

Comparative genomics projects at the Wellcome Sanger Institute and Genome Institute at Washington University trace kinase family expansion across metazoans, with orthologs characterized in model organisms handled at The Jackson Laboratory and European Molecular Biology Laboratory. Viral oncogenes from agents like Rous sarcoma virus informed evolutionary perspectives explored at Cold Spring Harbor Laboratory, while phylogenetic studies published with contributors from University of Cambridge and Stanford University map divergence between receptor and non-receptor lineages.

Category:Enzymes